# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 17

Extent: E+W+S+N.I.

In regulation 27 (amendment of regulation 36 (conditions for manufacturer's licence)) for “, omit paragraphs (4) to (7)” substitute—
“(a) in paragraph (4)—
(i) for “The requirements” substitute “ Where a manufacturer's licence relates to the manufacture or assembly of a medicinal product in, or import of a medicinal product into, Northern Ireland, the requirements ”;
(ii) for “provisions of a manufacturer's” substitute “ provisions of that ”;
(b) in paragraph (6), after “by way of wholesale dealing” insert “ in Northern Ireland ”.”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/17 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-17
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.